-+ 0.00%
-+ 0.00%
-+ 0.00%

BLACK DIAMOND THERAPEUTICS - FDA MEETING SUPPORTS PIVOTAL DEVELOPMENT AND POTENTIAL ACCELERATED APPROVAL BASED ON CNS-ORR - SEC FILING

Reuters·11/10/2026 11:33:18